Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Covington
Medtronic
Baxter
Federal Trade Commission

Generated: June 24, 2019

DrugPatentWatch Database Preview

ZYPREXA Drug Profile

Try a free trialSee Plans and Pricing

« Back to Dashboard

Which patents cover Zyprexa, and what generic alternatives are available?

Zyprexa is a drug marketed by Lilly and Eli Lilly Co and is included in four NDAs.

The generic ingredient in ZYPREXA is olanzapine pamoate. There are thirty-three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the olanzapine pamoate profile page.

US Patents and Regulatory Information for ZYPREXA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly ZYPREXA olanzapine INJECTABLE;INTRAMUSCULAR 021253-001 Mar 29, 2004 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly ZYPREXA olanzapine TABLET;ORAL 020592-006 Sep 9, 1997 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly ZYPREXA olanzapine TABLET;ORAL 020592-003 Sep 30, 1996 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly ZYPREXA ZYDIS olanzapine TABLET, ORALLY DISINTEGRATING;ORAL 021086-002 Apr 6, 2000 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Eli Lilly Co ZYPREXA RELPREVV olanzapine pamoate SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 022173-001 Dec 11, 2009 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for ZYPREXA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly ZYPREXA olanzapine TABLET;ORAL 020592-002 Sep 30, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Lilly ZYPREXA olanzapine TABLET;ORAL 020592-006 Sep 9, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Lilly ZYPREXA olanzapine TABLET;ORAL 020592-002 Sep 30, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Lilly ZYPREXA olanzapine TABLET;ORAL 020592-006 Sep 9, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Lilly ZYPREXA olanzapine TABLET;ORAL 020592-003 Sep 30, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Federal Trade Commission
Boehringer Ingelheim
Harvard Business School
Teva
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.